Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition

被引:27
作者
Rodrigues, Celia F. [1 ]
Rodrigues, Maria Elisa [1 ]
Henriques, Mariana [1 ]
机构
[1] Univ Minho, Ctr Biol Engn, LIBRO, CEB, Braga, Portugal
关键词
Candida glabrata; echinocandin; biofilm; matrix; antifungal drug; resistance; CHANGING EPIDEMIOLOGY; FUNGICIDAL ACTIVITIES; ANTIFUNGAL AGENTS; AMPHOTERICIN-B; BETA-GLUCAN; CASPOFUNGIN; MICAFUNGIN; RESISTANCE; ALBICANS; ANIDULAFUNGIN;
D O I
10.1080/08927014.2018.1472244
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Candidiases are the most recurrent fungal infections, especially among immunosuppressed patients. Although Candida albicans is still the most widespread isolated species, non-Candida albicans Candida species have been increasing. The goal of this work was to determine the susceptibility of C. glabrata biofilms to echinocandins and to evaluate their effect on the biofilm matrix composition, comparing the results with other Candida species. Drug susceptibilities were assessed through the determination of minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC) and minimum biofilm eradication concentration (MBEC) of caspofungin (Csf) and micafugin (Mcf). The -1,3 glucans content of the matrices was assessed after contact with the drugs. The data suggest that, generally, after contact with echinocandins, the concentration of -1,3 glucans increased. These adjustments in the matrix composition of C. glabrata biofilms and the chemical differences between Csf and Mcf, seem responsible and may determine the effectivity of the drug responses.
引用
收藏
页码:569 / 578
页数:10
相关论文
共 75 条
[1]   Penetration of Candida biofilms by antifungal agents [J].
Al-Fattani, MA ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3291-3297
[2]  
[Anonymous], Version 10.0.2020-01-01
[3]   Echinocandin resistance: an emerging clinical problem? [J].
Arendrup, Maiken C. ;
Perlin, David S. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2014, 27 (06) :484-492
[4]   Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C-krusei when Adopting the Revised CLSI Caspofungin Breakpoints [J].
Arendrup, Maiken Cavling ;
Pfaller, Michael A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) :3965-3968
[5]   Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations [J].
Arendrup, Maiken Cavling ;
Perlin, David S. ;
Jensen, Rasmus Hare ;
Howard, Susan Julie ;
Goodwin, Joanne ;
Hope, William .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) :2435-2442
[6]   Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata [J].
Barchiesi, F ;
Spreghini, E ;
Tomassetti, S ;
Arzeni, D ;
Giannini, D ;
Scalise, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) :4989-4992
[7]   Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms [J].
Cataldi, Valentina ;
Di Campli, Emanuela ;
Fazii, Paolo ;
Traini, Tonino ;
Cellini, Luigina ;
Di Giulio, Mara .
MEDICAL MYCOLOGY, 2017, 55 (06) :624-634
[8]   In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth [J].
Cateau, Estelle ;
Rodier, Marie-Helene ;
Imbert, Christine .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) :153-155
[9]   Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone [J].
Cateau, Estelle ;
Berjeaud, Jean-Marc ;
Imbert, Christine .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (04) :380-384
[10]   Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance [J].
Chandra, J ;
Kuhn, DM ;
Mukherjee, PK ;
Hoyer, LL ;
McCormick, T ;
Ghannoum, MA .
JOURNAL OF BACTERIOLOGY, 2001, 183 (18) :5385-5394